The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks trim losses on Greek hopes, Chinese stimulus

Wed, 04th Feb 2015 17:09

A late rally helped the FTSE 100 to erase most of its losses on Wednesday as optimism surrounding Greece and stimulus measures in China lifted sentiment, though stocks still finished in the red after hitting a five-month high the previous day.London's Footsie ended the session down 0.2% at 6,860.02, bouncing strongly in the last couple of hours after hitting an intraday low of 6,804.10, with pharma heavyweight Glaxosmithkline rising after its results announcement.Greece's prime minister Alexis Tsipras said in a press conference that he believes a debt relief deal can be met without the country leaving the EU. Tsipras said despite not having a deal yet, the country is "moving in the right direction".The prime minister travelled to Brussels to propose the new government's debt-swap plan to EU Commission president Jean-Claude Juncker. Greece has backed down from calling for a total debt write-off and has instead proposed swapping outstanding debt for new growth-linked bonds.Meanwhile, Greek finance minister Yanis Varoufakis, who held a meeting in Frankfurt with European Central Bank head Mario Draghi, said that discussions about easing the terms of the country's bailout were "very fruitful".Elsewhere, the People's Bank of China (PBoC) trimmed the banks' reserve requirement ratio by 50 basis points to 19.5%, the first such cut since May 2012, in an effort to boost lending into the real economy.According to FXTM analyst Jameel Ahmad, the PBoC was the 16th central bank across the globe to ease monetary policy this year in a move that "will be seen by many as a direct response to continued indications of slowing domestic momentum". He said the cut in the reserve requirement will be judged "by the markets as a positive move to reinvigorate economic growth".A raft of service-sector data was released during Wednesday session, showing that growth had picked up in the UK, Eurozone and US but eased in China.Glaxo leads late rallySales, profits and earnings slumped during the last quarter of the year at drugmaker GlaxoSmithKline due to headwinds in the US market, though the company pleased investors after confirming it would return £4bn cash from its deal with Novartis.Others in the pharma sector was also in demand, such as Astrazeneca, Hikma and Synergy Health with the latter benefiting after reporting a solid acceleration in underlying revenue growth in its third quarter.In its first set of results since slimming down its name to Sky and absorbing its German and Italian sister companies, the satellite broadcaster delivered a strong set of interim figures and cited good momentum in all its markets, causing shares to rise.Half-yearly results from fund manager and savings outfit Hargreaves Lansdown showed record assets under administration and growing client numbers, though shares fell sharply after revenues and profits came in shy of City expectations.Oil stocks were stuck in the red as the recent rally in crude prices came to an end with Brent falling 2.9%. Shell, Tullow, Afren and BHP Billiton all declined. Market MoverstechMARK 3,083.09 +0.68%FTSE 100 6,860.02 -0.17%FTSE 250 16,571.64 +0.01%FTSE 100 - RisersITV (ITV) 230.60p +3.64%ARM Holdings (ARM) 1,069.00p +3.09%easyJet (EZJ) 1,778.00p +2.72%Wolseley (WOS) 3,888.00p +1.94%CRH (CRH) 1,779.00p +1.89%Barratt Developments (BDEV) 470.00p +1.78%GlaxoSmithKline (GSK) 1,476.00p +1.58%Ashtead Group (AHT) 1,079.00p +1.41%Burberry Group (BRBY) 1,796.00p +1.41%International Consolidated Airlines Group SA (CDI) (IAG) 542.00p +1.40%FTSE 100 - FallersHargreaves Lansdown (HL.) 966.00p -7.56%Tullow Oil (TLW) 395.90p -5.15%Morrison (Wm) Supermarkets (MRW) 181.50p -2.42%Sainsbury (J) (SBRY) 266.70p -2.16%BHP Billiton (BLT) 1,527.00p -2.02%Aggreko (AGK) 1,596.00p -1.84%Anglo American (AAL) 1,150.00p -1.71%BG Group (BG.) 932.00p -1.38%Intertek Group (ITRK) 2,398.00p -1.28%SABMiller (SAB) 3,528.50p -1.27%FTSE 250 - RisersRank Group (RNK) 185.50p +4.80%Petra Diamonds Ltd.(DI) (PDL) 158.20p +4.42%AO World (AO.) 319.50p +4.28%Booker Group (BOK) 153.50p +3.44%Brown (N.) Group (BWNG) 448.60p +3.08%AL Noor Hospitals Group (ANH) 927.50p +3.00%Countrywide (CWD) 496.80p +2.88%Lonmin (LMI) 172.30p +2.62%Ultra Electronics Holdings (ULE) 1,778.00p +2.48%Howden Joinery Group (HWDN) 425.10p +2.46%FTSE 250 - FallersAfren (AFR) 11.10p -6.25%Premier Oil (PMO) 161.10p -5.79%Hunting (HTG) 456.20p -4.70%Wood Group (John) (WG.) 596.00p -4.03%Aveva Group (AVV) 1,390.00p -3.67%Ladbrokes (LAD) 120.10p -3.15%Thomas Cook Group (TCG) 126.10p -3.00%Interserve (IRV) 541.50p -2.96%Diploma (DPLM) 755.50p -2.58%Petrofac Ltd. (PFC) 742.50p -2.24%
More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.